NRG DT001

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Sarcoma

Status:

New, Open

A Phase Ib Trial of Neoadjuvant AMG-232 Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)

NCT#03217266

Cohort A is temporarily closed to accrual effective immediately because 3 patients have been enrolled, which is the maximum allowed per protocol. The cohort A of this trial will be temporarily closed for at least 9 weeks until all 3 patients complete the DLT evaluation period.